Nurix Therapeutics, Inc. (NRIX) Earnings
Nurix Therapeutics, Inc. is expected to report next earnings on July 9, 2026 (in NaN days), with a consensus EPS estimate of $-0.73. NRIX has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise +0.6% over the last four).
Next earnings
Jul 9, 2026in NaN days
EPS est $-0.73 · Revenue est $16M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise +0.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 8, 2026 | $-0.76 | $-0.79 | -3.9% | $6M | -56.1% |
| Jan 28, 2026 | $-0.84 | $-0.82 | +2.4% | $14M | -13.0% |
| Oct 9, 2025 | $-0.84 | $-1.03 | -22.6% | $8M | -35.6% |
| Jul 9, 2025 | $-0.71 | $-0.52 | +26.8% | $44M | +151.6% |
| Apr 8, 2025 | $-0.72 | $-0.67 | +6.9% | $18M | +16.6% |
| Jan 28, 2025 | $-0.67 | $-0.75 | -11.9% | $13M | -10.1% |
| Oct 11, 2024 | $-0.67 | $-0.67 | +0.0% | $13M | -1.7% |
| Jul 11, 2024 | $-0.66 | $-0.71 | -7.6% | $12M | -45.3% |
| Apr 10, 2024 | $-0.80 | $-0.76 | +5.0% | $17M | -4.1% |
| Feb 15, 2024 | $-0.51 | $-0.77 | -51.0% | $15M | -31.9% |
| Oct 12, 2023 | $-0.69 | $-0.68 | +1.4% | $18M | +15.6% |
| Jul 13, 2023 | $-0.63 | $-0.45 | +28.6% | $31M | +17.0% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.